Bhatia Ansh, Bryant Evan Hank, Fox Bradley, Richardson Andrew, Leichter Jeffrey, Mohan Prasoon
Seth GS Medical College and KEM Hospital, Mumbai, Maharastra, India.
University of Miami Miller School of Medicine, Miami, FL.
Ann Vasc Surg. 2023 Feb;89:166-173. doi: 10.1016/j.avsg.2022.09.055. Epub 2022 Oct 31.
The spleen is the most commonly injured visceral organ in blunt abdominal trauma. Post-splenectomy infection risk has led to the shift toward spleen preserving procedures and splenic artery embolization (SAE) is now the treatment of choice for hemodynamically stable patients with splenic injury. This study aims to assess the long-term effect of SAE on splenic volume and platelet count.
Using CPT codes, 66 patients who underwent SAE were identified, and 14 of those who had the necessary imaging and laboratory follow-up were included in the study. Indications for SAE were portal hypertension in 8 patients, bleeding in 4 patients, and thrombocytopenia in 1, and one patient had a separate indication. Splenic volume was calculated by automated volumetric software (Aquarius, TeraRecon, Inc.). Paired t-tests were performed to compare splenic volume and platelets before and after SAE.
Fourteen patients (7 males, 7 females) with a mean age of 51 ± 11.95 years underwent SAE and were followed by a repeat computed tomography scan at an average of 733.57 days. Nine SAEs were performed using vascular plugs, 3 using micro coils, and 2 out of that were with Gelfoam slurry, and 2 using coils only. All embolizations were technically successful with complete cessation of flow. Mean splenic volumes pre- and post-SAE were 903.5 ± 523.73 cm and 746.5 ± 511.95 cm, respectively, representing a mean decrease of 8.31% compared to baseline [P = 0.346]. Minimum platelet counts (x10) pre-SAE (within 3 months) and post-SAE (2 weeks to 3 months after the procedure) were 55.79 ± 57.11 and 116 ± 145.40, respectively. The minimum platelet count showed a statistically significant mean increase of 134.92% (P = 0.033).
The splenic volume is not altered significantly by SAE in the long term. Similarly, the platelet count is also not significantly altered at 3 months follow-up. This study, although small, suggests that SAE is a safe intervention that can preserve splenic volume and function in the long term.
脾脏是钝性腹部创伤中最常受损的内脏器官。脾切除术后的感染风险促使治疗方法转向保留脾脏的手术,而脾动脉栓塞术(SAE)目前是血流动力学稳定的脾损伤患者的首选治疗方法。本研究旨在评估SAE对脾体积和血小板计数的长期影响。
使用CPT编码识别66例行SAE的患者,其中14例有必要的影像学和实验室随访资料纳入本研究。SAE的适应证为门静脉高压8例、出血4例、血小板减少1例,另有1例有其他适应证。脾体积通过自动容积软件(Aquarius,TeraRecon公司)计算。采用配对t检验比较SAE前后的脾体积和血小板数量。
14例患者(7例男性,7例女性)平均年龄51±11.95岁,接受了SAE治疗,并在平均733.57天进行了重复计算机断层扫描。9例SAE使用血管栓塞物,3例使用微线圈,其中2例联合明胶海绵,2例仅使用线圈。所有栓塞技术均成功,血流完全停止。SAE前后脾平均体积分别为903.5±523.73 cm和746.5±511.95 cm,与基线相比平均减少8.31%[P = 0.346]。SAE前(3个月内)和SAE后(术后2周~3个月)的最低血小板计数(×10)分别为55.79±57.11和116±145.40。最低血小板计数平均增加134.92%,差异有统计学意义(P = 0.033)。
长期来看,SAE对脾体积无明显影响。同样,随访3个月时血小板计数也无明显变化。本研究虽然样本量小,但提示SAE是一种安全的干预措施,可长期保留脾体积和功能。